INHALT

Commission Decision of 22 February 2011 concerning the adoption of a financing decision for 2011 in the framework of the second programme of Community action in the field of health (2008-2013) and on the selection, award and other criteria for financial contributions to the actions to this programme Text with EEA relevance

COMMISSION DECISION
of 22 February 2011
concerning the adoption of a financing decision for 2011 in the framework of the second programme of Community action in the field of health (2008-2013) and on the selection, award and other criteria for financial contributions to the actions to this programme
(Text with EEA relevance)
Article 1
Article 2
Article 3
Article 4
Article 5
Article 6
ANNEX I
Work Plan 2011 for the second programme of Community action in the field of health (2008-13)
1. GENERAL CONTEXT
1.1.
Policy and legal context
1.2.
Resources
2. FINANCING MECHANISMS
2.1.
Project grants
2.2.
Operating grants
2.3.
Grants for joint actions
2.4.
Conference grants
2.4.1.
Presidency conferences –
De jure
monopoly
2.4.2.
Other conferences
2.5.
Direct grant agreements with international organisations
2.6.
Procurement
2.7.
Other actions
3. PRIORITIES FOR 2011
Health information and advice
Diseases
Health determinants
Health systems
Legislation on products and substances
3.1.
Actions under the first objective ‘Improve citizens’ health security’
3.1.1.
Protect citizens against health threats (Point 1.1.1 in Annex to the Health Programme)
3.1.1.1. Project on multi-sectoral preparedness and health-security: public health preparedness and response planning in the field of pandemic influenza and other serious cross-border health threats, including bio-threats.
3.1.1.2. Project on crisis communication in the area of risk management
3.1.1.3. Study on the environmental risks of medicinal products
3.1.1.4. HIV and co-infections prevention strategies — concepts for the future
3.1.2.
Improve citizens’ safety — Scientific advice (Point 1.2.1 in Annex to the Health Programme)
3.1.2.1. Special indemnities to Scientific Committees
3.1.2.2. Technical and organisational assistance for the functioning of the Scientific Committees and communication on risks
3.1.3.
Improve citizens’ safety — Safety of blood, tissues, cells and organs (Point 1.2.2 in Annex to the Health Programme)
3.1.3.1. Ad hoc cooperation with the Council of Europe on specific matters relating to substances of human origin
3.1.3.2. Organisation of training sessions for inspectors in the field of blood and blood components
3.1.3.3. Assisting Member States in reaching the full potential of deceased and living organ donation
3.1.3.4. Supporting registers for the European single coding system for human tissues and cells
3.1.4.
Improve citizens’ safety — Improving patient safety through high-quality and safe healthcare (Point 1.2.3 in Annex to the Health Programme)
3.1.4.1. Patient safety and quality of healthcare
3.2.
Actions under the second objective ‘Promote health’
3.2.1.
Identifying the causes of, addressing and reducing health inequalities and promoting investment in health in cooperation with other EU policies and funds (Point 2.1.2 in Annex to the Health Programme)
3.2.1.1. Reducing health inequalities: preparation for action plans and structural funds projects
3.2.1.2. European Review of Social Determinants and the Health Divide: collaboration with WHO to produce policy guidelines and tools for addressing health inequalities
3.2.2.
Addressing health determinants to promote and improve physical and mental health and taking action on key factors such as nutrition and physical activity, tobacco, and alcohol (Point 2.2.1 in Annex to the Health Programme)
3.2.2.1. Monitoring the implementation of the European Strategy for Nutrition and Physical Activity jointly with WHO
3.2.2.2. Communication campaign on tobacco prevention
3.2.2.3. Study on the tobacco industry’s new marketing, sales and product strategies
3.2.2.4. Administrative agreement with the Joint Research Centre for the provision of scientific policy support for the implementation of the Tobacco Products Directive and FCTC
3.2.2.5. Good practice on brief interventions to address alcohol use disorders in primary health care, workplace health services, emergency care and social services
3.2.2.6. Evaluating the structures put in place to implement the EU Alcohol Strategy
3.2.2.7. Scientific and technical support to the implementation of EU policies in the field of nutrition, alcohol and Health Forum activities
3.2.3.
Prevention of major and rare diseases (Point 2.2.2 in Annex to the Health Programme)
3.2.3.1. Support to actions in line with the Commission Communication on Action against Cancer: European Partnership
3.2.3.2. Scientific and technical support to the European Partnership for Action against Cancer and follow-up of the implementation of the Council Recommendation on Cancer Screening
3.2.3.3. Support to European rare diseases information networks
3.2.3.4. Support to the implementation of the Council Recommendation and the Commission Communication on Rare Diseases
3.3.
Actions under the third objective ‘Generate and disseminate health information and knowledge’
3.3.1.
European Health Information System (Point 3.2.1 in Annex to the Health Programme)
3.3.1.1. Support creation of pilot network of hospitals related to payment of care for cross border patients
3.3.1.2. Pooling of experts on health systems
3.3.1.3. Complementary joint action on pilot HTA’s on targeted health technologies
3.3.1.4. Cross-border eHealth instruments as supporting tools for medical information and research
3.3.1.5. Collaboration with OECD on health information
3.3.1.6. Setting up guidelines in support of ePrescription interoperability
3.3.1.7. Support to the European system of health information and diffusion of innovation
3.3.1.8. Commission membership of the European Observatory on Health Policies and Health Systems
3.3.2.
Dissemination and application of health information (Point 3.2.2 in Annex to the Health Programme)
3.3.2.1. Communication and promotion of policies and Health Programme results and evaluation of activities related to communication
3.3.2.2. Maintenance, updating and management of the EU Health Portal and health websites, including in-house services
3.3.2.3. IT Master Plan
3.3.3.
Analysis and reporting (Point 3.2.3 in Annex to the Health Programme)
3.3.3.1. Research agenda for the EU on health economic evaluations
3.3.3.2. Health reports and analysis
3.3.3.3. Feasibility study on health workforce
3.3.3.4. Study on the package leaflets and the summaries of product characteristics of medicinal products for human use
ANNEX II
Criteria for financial contributions to projects under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(1)(a)
1. GENERAL PRINCIPLES
2. EXCLUSION AND ELIGIBILITY CRITERIA
3. SELECTION CRITERIA
4. AWARD CRITERIA
ANNEX III
Criteria for financial contributions to the functioning of a non-governmental body or a specialised network (operating grants) under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(1)(b)
1. EXCLUSION AND ELIGIBILITY CRITERIA
2. SELECTION CRITERIA
3. AWARD CRITERIA
ANNEX IV
Criteria for financial contributions to joint actions under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(3)
1. EXCLUSION AND ELIGIBILITY CRITERIA
2. SELECTION CRITERIA
3. AWARD CRITERIA
ANNEX V
Criteria for financial contributions for conferences under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Article 4(1)(a)
1. EXCLUSION AND ELIGIBILITY CRITERIA
2. SELECTION CRITERIA
3. AWARD CRITERIA
ANNEX VI
Criteria for independence from industry, commercial and business or other conflicting interest applicable to operating grants and grants for joint actions under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Articles 4.1(b) and 4.3
1. LEGAL INDEPENDENCE
2. FINANCIAL INDEPENDENCE
3. TRANSPARENCY OF THE APPLICANT’S ACTIVITIES AND FUNDING
4. ASSESSMENT OF INDEPENDENCE
ANNEX VII
Criteria for exceptional utility for project grants and operating grants under the second programme of Community action in the field of health (2008-2013)
Decision No 1350/2007/EC, Articles 4(1)(a), 4(1)(b) and 4(3)
1. GENERAL PRINCIPLES
2. EXCEPTIONAL UTILITY OF PROJECTS
3. EXCEPTIONAL UTILITY OF OPERATING GRANTS